List of Chapters/Sections(Table Of Content)
1 Introduction to Research & Analysis Reports
1.1 Biologics Contract Manufacturing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biologics Contract Manufacturing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biologics Contract Manufacturing Overall Market Size
2.1 Global Biologics Contract Manufacturing Market Size: 2021 VS 2028
2.2 Global Biologics Contract Manufacturing Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Biologics Contract Manufacturing Players in Global Market
3.2 Top Global Biologics Contract Manufacturing Companies Ranked by Revenue
3.3 Global Biologics Contract Manufacturing Revenue by Companies
3.4 Top 3 and Top 5 Biologics Contract Manufacturing Companies in Global Market, by Revenue in 2021
3.5 Global Companies Biologics Contract Manufacturing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Biologics Contract Manufacturing Players in Global Market
3.6.1 List of Global Tier 1 Biologics Contract Manufacturing Companies
3.6.2 List of Global Tier 2 and Tier 3 Biologics Contract Manufacturing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Biologics Contract Manufacturing Market Size Markets, 2021 & 2028
4.1.2 MABs
4.1.3 Recombinant Protein
4.1.4 Others
4.2 By Type - Global Biologics Contract Manufacturing Revenue & Forecasts
4.2.1 By Type - Global Biologics Contract Manufacturing Revenue, 2017-2022
4.2.2 By Type - Global Biologics Contract Manufacturing Revenue, 2023-2028
4.2.3 By Type - Global Biologics Contract Manufacturing Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Biologics Contract Manufacturing Market Size, 2021 & 2028
5.1.2 Oncology
5.1.3 Immunological Disorders
5.1.4 Cardiovascular Disorders (CVDs)
5.1.5 Hematological Disorders
5.1.6 Others
5.2 By Application - Global Biologics Contract Manufacturing Revenue & Forecasts
5.2.1 By Application - Global Biologics Contract Manufacturing Revenue, 2017-2022
5.2.2 By Application - Global Biologics Contract Manufacturing Revenue, 2023-2028
5.2.3 By Application - Global Biologics Contract Manufacturing Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Biologics Contract Manufacturing Market Size, 2021 & 2028
6.2 By Region - Global Biologics Contract Manufacturing Revenue & Forecasts
6.2.1 By Region - Global Biologics Contract Manufacturing Revenue, 2017-2022
6.2.2 By Region - Global Biologics Contract Manufacturing Revenue, 2023-2028
6.2.3 By Region - Global Biologics Contract Manufacturing Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Biologics Contract Manufacturing Revenue, 2017-2028
6.3.2 US Biologics Contract Manufacturing Market Size, 2017-2028
6.3.3 Canada Biologics Contract Manufacturing Market Size, 2017-2028
6.3.4 Mexico Biologics Contract Manufacturing Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Biologics Contract Manufacturing Revenue, 2017-2028
6.4.2 Germany Biologics Contract Manufacturing Market Size, 2017-2028
6.4.3 France Biologics Contract Manufacturing Market Size, 2017-2028
6.4.4 U.K. Biologics Contract Manufacturing Market Size, 2017-2028
6.4.5 Italy Biologics Contract Manufacturing Market Size, 2017-2028
6.4.6 Russia Biologics Contract Manufacturing Market Size, 2017-2028
6.4.7 Nordic Countries Biologics Contract Manufacturing Market Size, 2017-2028
6.4.8 Benelux Biologics Contract Manufacturing Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Biologics Contract Manufacturing Revenue, 2017-2028
6.5.2 China Biologics Contract Manufacturing Market Size, 2017-2028
6.5.3 Japan Biologics Contract Manufacturing Market Size, 2017-2028
6.5.4 South Korea Biologics Contract Manufacturing Market Size, 2017-2028
6.5.5 Southeast Asia Biologics Contract Manufacturing Market Size, 2017-2028
6.5.6 India Biologics Contract Manufacturing Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Biologics Contract Manufacturing Revenue, 2017-2028
6.6.2 Brazil Biologics Contract Manufacturing Market Size, 2017-2028
6.6.3 Argentina Biologics Contract Manufacturing Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Biologics Contract Manufacturing Revenue, 2017-2028
6.7.2 Turkey Biologics Contract Manufacturing Market Size, 2017-2028
6.7.3 Israel Biologics Contract Manufacturing Market Size, 2017-2028
6.7.4 Saudi Arabia Biologics Contract Manufacturing Market Size, 2017-2028
6.7.5 UAE Biologics Contract Manufacturing Market Size, 2017-2028
7 Players Profiles
7.1 Wuxi Biologics
7.1.1 Wuxi Biologics Corporate Summary
7.1.2 Wuxi Biologics Business Overview
7.1.3 Wuxi Biologics Biologics Contract Manufacturing Major Product Offerings
7.1.4 Wuxi Biologics Biologics Contract Manufacturing Revenue in Global Market (2017-2022)
7.1.5 Wuxi Biologics Key News
7.2 Abzena Ltd.
7.2.1 Abzena Ltd. Corporate Summary
7.2.2 Abzena Ltd. Business Overview
7.2.3 Abzena Ltd. Biologics Contract Manufacturing Major Product Offerings
7.2.4 Abzena Ltd. Biologics Contract Manufacturing Revenue in Global Market (2017-2022)
7.2.5 Abzena Ltd. Key News
7.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
7.3.1 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Corporate Summary
7.3.2 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Business Overview
7.3.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biologics Contract Manufacturing Major Product Offerings
7.3.4 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biologics Contract Manufacturing Revenue in Global Market (2017-2022)
7.3.5 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Key News
7.4 Boehringer Ingelheim GmbH
7.4.1 Boehringer Ingelheim GmbH Corporate Summary
7.4.2 Boehringer Ingelheim GmbH Business Overview
7.4.3 Boehringer Ingelheim GmbH Biologics Contract Manufacturing Major Product Offerings
7.4.4 Boehringer Ingelheim GmbH Biologics Contract Manufacturing Revenue in Global Market (2017-2022)
7.4.5 Boehringer Ingelheim GmbH Key News
7.5 Lonza
7.5.1 Lonza Corporate Summary
7.5.2 Lonza Business Overview
7.5.3 Lonza Biologics Contract Manufacturing Major Product Offerings
7.5.4 Lonza Biologics Contract Manufacturing Revenue in Global Market (2017-2022)
7.5.5 Lonza Key News
7.6 SamsungBiologics
7.6.1 SamsungBiologics Corporate Summary
7.6.2 SamsungBiologics Business Overview
7.6.3 SamsungBiologics Biologics Contract Manufacturing Major Product Offerings
7.6.4 SamsungBiologics Biologics Contract Manufacturing Revenue in Global Market (2017-2022)
7.6.5 SamsungBiologics Key News
7.7 Abbvie
7.7.1 Abbvie Corporate Summary
7.7.2 Abbvie Business Overview
7.7.3 Abbvie Biologics Contract Manufacturing Major Product Offerings
7.7.4 Abbvie Biologics Contract Manufacturing Revenue in Global Market (2017-2022)
7.7.5 Abbvie Key News
7.8 Catalent
7.8.1 Catalent Corporate Summary
7.8.2 Catalent Business Overview
7.8.3 Catalent Biologics Contract Manufacturing Major Product Offerings
7.8.4 Catalent Biologics Contract Manufacturing Revenue in Global Market (2017-2022)
7.8.5 Catalent Key News
7.9 Bioreliance
7.9.1 Bioreliance Corporate Summary
7.9.2 Bioreliance Business Overview
7.9.3 Bioreliance Biologics Contract Manufacturing Major Product Offerings
7.9.4 Bioreliance Biologics Contract Manufacturing Revenue in Global Market (2017-2022)
7.9.5 Bioreliance Key News
7.10 Thermo Fischer (Patheon)
7.10.1 Thermo Fischer (Patheon) Corporate Summary
7.10.2 Thermo Fischer (Patheon) Business Overview
7.10.3 Thermo Fischer (Patheon) Biologics Contract Manufacturing Major Product Offerings
7.10.4 Thermo Fischer (Patheon) Biologics Contract Manufacturing Revenue in Global Market (2017-2022)
7.10.5 Thermo Fischer (Patheon) Key News
7.11 Eurofins CDMO
7.11.1 Eurofins CDMO Corporate Summary
7.11.2 Eurofins CDMO Business Overview
7.11.3 Eurofins CDMO Biologics Contract Manufacturing Major Product Offerings
7.11.4 Eurofins CDMO Biologics Contract Manufacturing Revenue in Global Market (2017-2022)
7.11.5 Eurofins CDMO Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer